About this trial
In this project, we will train a ChatGPT to provide real-time answers to questions related to the SIV for older adults in Hong Kong.
This study aims to evaluate the usability, acceptability, and preliminary effectiveness of the ChatGPT among 50 community-living people aged 65 years and above in Hong Kong.
The primary objectives are to evaluate the usability and acceptability (including the extent of usage and subjective experiences of behavioural, cognitive, and affective engagement) of the ChatGPT at the end of the 4-week intervention period (T1).
The secondary objectives are to evaluate the following conditions measured at T1, as compared to those measured at baseline (T0):
1. Self-reported uptake of SIV in the past month. 2. Changes in behavioural intention to receive SIV for the approaching flu season. 3. Changes in knowledge and attitudes related to SIV.
Eligibility criteria
Qualifiers
Aged ≥65 years;
Possession of a Hong Kong ID;
Able to speak and comprehend Cantonese;
Have a smartphone with internet access;
Disqualifiers
With diagnosis of cognitive impairment or dementia;
Either blindness or deafness;
With known contraindications to the SIV as indicated by the Hong Kong Centre for Health Protection
Trial design
Treatments tested in this trial
- Access to a trained ChatGPT